Podcast: Substance Use Disorders: Recognition and Treatment
Evaluation and Credit: https://www.surveymonkey.com/r/MedChat24
Target Audience
This activity is targeted toward primary care specialties.
Statement of Need
It has been estimated that 29% if people misuse prescription pain relievers for chronic pain; and between 8-12% develop a use disorder. In 2017 the Department of Human and Health Services declared opioid crisis a public emergency and Kentucky is one of the leading states in abuse in the US. Based on these statistics most providers have or will encounter a patient in their practice with SUD and therefore recognition and management is key for optimal patient outcomes.
ObjectivesAt the conclusion of this offering, the participant will be able to:
John J. Wernert, M.D., MHA, DLFAPA Executive Medical Director Norton Behavioral Medicine
Speaker
Kelly Cooper, M.D. Medical Director, Addiction Services Norton Behavioral Medicine
Moderator, Speaker and Planner Disclosures
The speaker, moderator and planners for this activity have no potential or actual conflicts of interest to disclose.
Commercial Support
There was no commercial support for this activity.
Physician Credits
American Medical Association
Accreditation
Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians.
Designation
Norton Healthcare designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
HB1 / Prescribing Controlled Substances
The Kentucky Board of Medical Licensure has approved the podcast Substance Use Disorders: Recognition and Treatment for .75 HB1 credit hours. ID# 0221-H.75-NHC1f
Date of Original Release |March 2021
Course Termination Date | March 31, 2023
Updated Termination Date | March 2024; this information has been reviewed and is determined to still be current.
Contact Information | Center for Continuing Medical Education; (502) 446-5955 or cme@nortonhealthcare.org
Resources for Additional Study
National Institute on Drug Abuse
Beyond Buprenorphine: Models of Follow-up Care for Opioid Use Disorder in the Emergency Department
https://pubmed.ncbi.nlm.nih.gov/33207174/
A comprehensive multivariate model of biopsychosocial factors associated with opioid misuse and use disorder in a 2017-2018 United States national survey
https://pubmed.ncbi.nlm.nih.gov/33208132/
Converging Crises: Caring for Hospitalized Adults With Substance Use Disorder in the Time of COVID-19
https://pubmed.ncbi.nlm.nih.gov/32966196/
Treatment for Anxiety and Substance Use Disorders During the COVID-19 Pandemic: Challenges and Strategies
https://pubmed.ncbi.nlm.nih.gov/33156267/
There are also 1 question screens that are validated.
If the response to either are positive, then the screen is positive and further evaluation is needed.